Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoplasms, Urinary Bladder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00072150
What this trial is testing

Phase II Trial Of PS-341 (Bortezomib) In Patients With Previously Treated Advanced Urothelial Tract Transitional Cell Carcinoma

Who this might be right for
Metastatic Transitional Cell Cancer of the Renal Pelvis and UreterRecurrent Bladder CancerRecurrent Transitional Cell Cancer of the Renal Pelvis and Ureter+7 more
National Cancer Institute (NCI) 40
Large-scale testing (Phase 3)Looking for participantsNCT05786716
What this trial is testing

DETERMINE Trial Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With HER2 Amplification or Activating Mutations

Who this might be right for
Haematological MalignancyColorectal NeoplasmsUrinary Bladder Neoplasm+8 more
Cancer Research UK 30
Not applicableUnknownNCT03563443
What this trial is testing

Genomic Imprinting Testing for Diagnosis of Bladder Cancer

Who this might be right for
Bladder CancerUrine MarkingDiagnoses Disease
Changhai Hospital 300
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07151560
What this trial is testing

Efficacy and Safety of Two Bladder-preserving Treatment Durations With Disitamab Vedotin Plus Toripalimab Combination in Her2-expressing Muscle-invasive Bladder Cancer: A Phase II, Open-Label, Randomized Clinical Trial

Who this might be right for
Urology
Renmin Hospital of Wuhan University 60
Not applicableStudy completedNCT03789682
What this trial is testing

CD155 in Bladder Cancer

Who this might be right for
Bladder Cancer
Fudan University 151
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06829823
What this trial is testing

Clinical Trial of Ablation Therapy in Participants With Intermediate-Risk Non-Muscle Invasive Papillary Bladder Cancer

Who this might be right for
Non-muscle Invasive Bladder Cancer (NMIBC)
ImmunityBio, Inc. 20
Large-scale testing (Phase 3)Ended earlyNCT04197986
What this trial is testing

Oral Infigratinib for the Adjuvant Treatment of Subjects With Invasive Urothelial Carcinoma With Susceptible FGFR3 Genetic Alterations

Who this might be right for
Upper Tract Urothelial CarcinomasUrothelial Bladder Cancer
QED Therapeutics, a BridgeBio company 39
Large-scale testing (Phase 3)Not Yet RecruitingNCT05810623
What this trial is testing

Single-Dose Intravesical Chemotherapy After Diagnostic URS

Who this might be right for
Upper Urinary Tract Urothelial CarcinomaBladder Cancer
David D'Andrea 394
Not applicableStudy completedNCT02217891
What this trial is testing

IFACT: Incidental Findings in Advanced Cancer Therapy

Who this might be right for
Breast CancerColorectal CancerBladder Cancer+1 more
Memorial Sloan Kettering Cancer Center 60
Post-approval studies (Phase 4)Study completedNCT00365508
What this trial is testing

Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit Smoking

Who this might be right for
Bladder CancerCervical CancerEsophageal Cancer+8 more
Fox Chase Cancer Center 642
Not applicableLooking for participantsNCT07339761
What this trial is testing

Supporting Sexual Health in Bladder Cancer Patients: A Sequential Mixed-Methods Intervention Study

Who this might be right for
Bladder CancerNon-Muscle-Invasive Bladder Cancer (NMIBC)Muscle-Invasive Bladder Carcinoma
University of Aarhus 30
Not applicableLooking for participantsNCT06289270
What this trial is testing

Microbiota in Urine and Urothelium Can be a Factor for Induction of Urinary Bladder Cancer. The Study Will Examine Urine and Bladder Tissues From Egyptian Male Patients and Controls Using Whole Genomic Sequencing Techniques and 16S rRNA. The Aim is to Elucidate Role of Microbiota in Bladder Cancer.

Who this might be right for
Microbiota in Patients With Urinary Bladder Carcinoma in Urine and Cancer Tissues
Theodor Bilharz Research Institute 38
Testing effectiveness (Phase 2)Active Not RecruitingNCT02717156
What this trial is testing

Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab in Solid Tumors

Who this might be right for
Stage IV Bladder Urothelial CarcinomaProstate CancerUrothelial Carcinoma
University of Southern California 70
Testing effectiveness (Phase 2)UnknownNCT04060459
What this trial is testing

Paclitaxel-binding Albumin and Cisplatin as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer

Who this might be right for
Bladder Cancer
Third Military Medical University 50
Not applicableLooking for participantsNCT06729346
What this trial is testing

Is the Normal Looking Bladder Mucosa on WL Cystoscopy During TURBT Really Normal and Can NBI Detect Hidden Tumor

Who this might be right for
Transition Cell Cancer
Armed Forces Institute of Urology, Rawalpindi 100
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06528483
What this trial is testing

Bladder Preservation With Sacituzumab Govitecan + Zimberelimab for Muscle-Invasive Bladder Cancer

Who this might be right for
Bladder CancerBladder Urothelial CarcinomaBladder Neoplasm+1 more
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 63
Early research (Phase 1)Looking for participantsNCT06963346
What this trial is testing

Study Investigating Intravesical HDAC Inhibition to Improve Response to Immuno-Oncology Agents

Who this might be right for
Bladder Cancer
H. Lee Moffitt Cancer Center and Research Institute 12
Testing effectiveness (Phase 2)Looking for participantsNCT07296705
What this trial is testing

Neoadjuvant Zanidatamab + Tislelizumab + Chemotherapy for Selective Bladder Preservation in HER2-Positive MIBC

Who this might be right for
Muscle Invasive Bladder Cancer (MIBC)
Fujian Medical University Union Hospital 25
Early research (Phase 1)Ended earlyNCT06714617
What this trial is testing

Evaluate BL-M17D1 in Patients w/HER2-Expressing/Mutant Advanced or Metastatic Solid Tumors

Who this might be right for
Breast Cancer Stage IIIHER2-positive Metastatic Breast CancerUnresectable Breast Carcinoma+11 more
SystImmune Inc. 3
Testing effectiveness (Phase 2)Study completedNCT00588640
What this trial is testing

Study of D-Methadone in Patients With Chronic Pain

Who this might be right for
PainBladder CancerBreast Cancer+9 more
Memorial Sloan Kettering Cancer Center 10
Next Page